The long roots of ibogaine: A journey from plant to pharmaceutical
Level 5 - mechanism / opinion, no new human data
Level 5 by design analogy for a narrative historical literature review
OpenAlex W7134229554 · doi:10.1556/2054.2026.00491
What was done
The authors conducted a non-systematic historical literature review evaluating the development of ibogaine prior to the 1960s. Using a postcolonial historiographical approach examining colonial botany, biopiracy, and intellectual property, the review analyzed three phases: French colonial acquisition and classification of iboga in the Congo Basin, the alkaloid's isolation in 1900 with subsequent early French pharmaceutical research, and the international commercialization of ibogaine-containing retail formulations.
What was found
The investigation identified multiple historical retail medicines containing ibogaine beyond Lambarène, specifically Dragées Nyrdahl, Grains des Anémiques, Syséros, Viris Lucet, Ibobiose, and Iperton. The review uncovered discounted records of local indigenous use in the Congo Basin that guided early-to-mid 20th-century medical research, as well as historical documentation showing ibogaine was used in Mexico in 1913 for treating a substance use disorder. The abstract reports no quantitative clinical metrics or numerical data.
Why it matters
The findings challenge dominant narratives that attribute the discovery of ibogaine's anti-addictive properties solely to Howard Lotsof in the 1960s, documenting prior application in 1913. It contextualizes modern pharmaceutical interest within historical colonial extraction and indigenous knowledge systems.
Limits
The study is a non-systematic historical review subject to selection and archival retrieval biases. The abstract does not quantify the number of sources reviewed and presents no quantitative clinical efficacy, pharmacokinetic, or safety outcome data.
Cited by
- supports Ibogaine was listed on the French pharmaceutical formulary from 1930 to 1966 under the brand name Lambarène as a daily microdose medication.